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ScienceDirectThe postsynaptic density (PSD) of all vertebrate species share a
highly complex proteome with 1000 conserved proteins that
function as sophisticated molecular computational devices.
Here, we review recent studies showing that this complexity
can be understood in terms of the supramolecular organization
of proteins, which self-assemble within a hierarchy of different
length scales, including complexes, supercomplexes and
nanodomains. We highlight how genetic and biochemical
approaches in mice are being used to uncover the native
molecular architecture of the synapse, revealing hitherto
unknown molecular structures, including highly selective
mechanisms for specifying the assembly of NMDAR-MAGUK
supercomplexes. We propose there exists a logical framework
that precisely dictates the subunit composition of synaptic
complexes, supercomplexes, and nanodomains in vivo.
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Introduction
In the early 1990s the available evidence suggested that a
handful of postsynaptic proteins were sufficient for the
functions of synaptic transmission and plasticity at
excitatory synapses in the brain. Fast synaptic
transmission mediated by AMPA subtypes of ionotropic
glutamate receptors could be modulated by Ca2+-calmod-
ulin Kinase II (CamKII) that was triggered by Ca2+ influx
via the N-methyl-D-aspartic acid receptor (NMDAR)
[1,2]. Glutamate receptors and the CamKII holoenzyme
were each recognised to be multiprotein complexes
comprised of receptor and kinase subunits respectively.
However, the discovery that the NMDAR physically
associates with many dozens of proteins [3,4,5] led to
the realization that receptors associated with vastwww.sciencedirect.com numbers of different proteins, which included other
complexes such as ion channels, adhesion and signalling
proteins [3]. Furthermore, the vertebrate postsynaptic
proteome was found to be far more complex than
anticipated and is comprised of 1000 highly conserved
proteins in mice [6–8], rats [9,10], humans [7,11] and
zebrafish [12]. It is highly unlikely that this molecular
machinery simply support a generic function of
transmission, because postsynaptic protein mutations in
mice result in differential functional and behavioural
phenotypes [13]. Moreover, at least 130 brain diseases,
including common and rare psychiatric and neurological
conditions, present with cognitive, motor, emotional
phenotypes [11]. Thus, understanding the organization
of the postsynaptic proteome is of fundamental impor-
tance to disease and the molecular basis of cognitive
function.
How are the vast numbers of postsynaptic proteins physi-
cally organised in the postsynaptic terminal? Do they
constitute a ‘soup’ of different proteins or is there a
molecular logic to the way they interact and function?
Over the last thirty years it has become apparent that
individual proteins are rarely deployed alone, but instead
execute their functions within complexes and other
higher-order molecular machines [14,15]. To generate a
molecular machine, individual protein subunits assemble
into complexes and these in turn associate to form super-
complexes (complexes of complexes) (Figure 1). Super-
complexes can be mega-Daltons in mass and perform
fundamental biological processes, as exemplified by the
respirasome, nuclear pore, proteasome, ribosome and
spliceosome [14]. In contrast to these supercomplexes
that are readily studied using cultured eukaryotic cells,
the supercomplexes of the synapse have been particularly
challenging to study because of the inherent complexity
of brain tissue and the low abundance of the
supercomplexes.
Studying the supramolecular organisation of
postsynaptic proteins
The majority of studies examining protein interactions
and protein assemblies in the synapse have relied on in
vitro methods, including yeast-2-hybrid interaction and
pull-down assays. While useful in identifying potential
binary interactions, these methods often mislead or do not
accurately reflect the organization of proteins in vivo,
especially when interactions are multivalent and involve
more than two components acting in concert. AnCurrent Opinion in Neurobiology 2017, 45:139–147
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Hierarchy of supramolecular organization in the postsynaptic proteome.
The genome and transcriptome encode individual proteins and instructs their hierarchical organization at different length scales into complexes,
supercomplexes and nanoclusters. Different synapses express different numbers of nanoclusters and these synapses are differentially distributed
into different brain regions, as indicated by the colour scheme (pink, regions of brain with predominantly single nanocluster synapses; blue,
regions with multiple nanoclusters) of the mouse hippocampus (adapted from Ref. [44]).important insight into how the vast number of postsyn-
aptic proteins are physically organized was obtained by a
biochemical screen using Blue Native PAGE (BNP) to
catalogue many functional classes including neurotrans-
mitter receptors, trans-synaptic/adhesion, ion channels,
signaling enzymes, scaffolds/adaptors and immediate-
early/local translation proteins [5]. Strikingly, 220 mouse
forebrain synaptic complexes and supercomplexes (5–20xCurrent Opinion in Neurobiology 2017, 45:139–147 the monomer size) were evident of which only seventeen
were previously known (Figure 2). These data provide a
molecular blueprint for further interrogation of the assem-
bly of the synapse. For example, this screen showed that
GABAA receptor subunits found at inhibitory synapses
partition between 500 kDa and 720 and 900 kDa
native complexes [5]. A more recent report elegantly
analyzed the composition of the 720 kDa native GABAAwww.sciencedirect.com
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Supramolecular ‘fingerprint’ of 65 forebrain proteins.
Adapted with permission from Ref. [5]. Native assemblies were detected by blue non-native PAGE immunoblot of mouse forebrain extracted with
various different detergents. Expected and unexpected/unknown native protein assemblies within each lane are indicated by open and filled
arrowheads, respectively. Native molecular mass indicated in mega-Daltons (MDa).receptor complex identifying neuroligin-2 and putative
auxiliary GABAA receptor subunits [16]. Thus, supramo-
lecular assembly is likely to be a general property of
synaptic proteins.
The major challenge is to biochemically isolate, identify
and characterise the constituents of these myriad com-
plexes and supercomplexes. Mass spectrometry of immu-
noprecipitated complexes, used to identify constituents
of these novel complexes [3] is critically dependent on
the efficiency and specificity of the antibody and the
availability or viability of knockout mice that are needed
in most cases to serve as negative controls. Nonetheless,
this approach has been particularly successful at identi-
fying auxiliary subunits of receptors found in various sub-
compartments of the neuron, including AMPA receptors
[17–19,20], kainic acid receptors [21], GABAB receptors
[22], GABAA receptors [16], and BK-Cav channel-channel
supercomplexes [23]. Except in rare cases where peptide
epitopes enable native elution [16,20,24], a disadvan-
tage of this approach is that samples must be denatured,www.sciencedirect.com which breaks apart the native complexes. This limiting
factor can prevent further study of the biochemical and
physiological function of complexes, as well as the iden-
tification of further subfamilies within a population of
complexes.
A method that can overcome these limitations is to
genetically modify the protein of interest so that it is
fused with a protein sequence that is well suited to
affinity purification and elution. Originally devised for
use in in vitro systems, these protein sequences have been
engineered into the genome of mice using gene-targeting
methods, thereby ‘tagging’ endogenous proteins and their
native assemblies. Typically, these tags are small domains
encoding high-affinity binding sites and when used in
tandem enable multiple steps of purification [25]. For
example, a commonly used tandem-affinity purification
(TAP)-tag includes Flag epitopes and hexahistidine tags,
which can be used for antibody and nickel affinity purifi-
cation, respectively. In this setting, wild type mice serve
as excellent negative controls for purifying endogenousCurrent Opinion in Neurobiology 2017, 45:139–147
142 Molecular neurosciencecomplexes. A key advantage in the design of these gene-
tags is the use of epitopes including Flag, for which there
are peptide reagents that trigger elution by competing for
binding to antibody-coupled resin, thereby releasing
populations of gene-tagged complexes in their native
state. This ‘gene-tagging’ approach has been successfully
applied as a C-terminal fusion to the abundant scaffold
protein, PSD95 [26], and as an N-terminal fusion (down-
stream of the signal peptide) on the first extracellular
domain of the membrane spanning GluN1 subunit of the
NMDAR [5]. Next, we will describe how these tagging
approaches were used to define complexes and super-
complexes containing NMDAR and PSD95.
Supramolecular organization of the NMDA
receptor
The heterotetrameric structure of recombinant NMDAR
has been shown in beautiful atomic detail by X-ray
crystallography and single-particle cryo-electron micros-
copy (cryo-EM). These have provided clues to the mech-
anism of ligand gating [27,28,29,30], albeit with many
‘stabilizing’ mutations and the absence of the entire C-
terminal domain (CTD), which accounts for 1/3 of the
protein coding sequence. A recent report revealed that in
vivo receptors were partitioned into two discrete popula-
tions: 0.8 MDa NMDAR complexes and 1.5 MDa
NMDAR supercomplexes [5]. The most abundant con-
stituents of the NMDAR supercomplexes in the forebrain
were the NMDAR channel subunits (GluN1, GluN2A,
and GluN2B) and two Membrane Associated Guanylate
Kinase (MAGUK) proteins (PSD95 and PSD93). Com-
bining gene-tagging (as described above) with biochemi-
cal methods, these distinct populations of the NMDAR
were purified and analysed. NMDAR complexes are
composed solely of ion channel subunits, whereas
NMDAR supercomplexes contain receptors bound to
50 different proteins including other ion channels, recep-
tors, adhesion proteins, and signalling enzymes [5].
What molecular mechanisms dictate the assembly of
diverse populations of NMDAR supercomplexes? Earlier
studies used the cytoplasmic domain of NMDAR GluN2
subunits to ‘fish’ for direct binding partners and this
retrieved the four paralogs in the MAGUK family
(PSD95, PSD93, SAP102, SAP97), which contain two
PDZ domains each and can bind to a short peptide
sequence (ES[D/E]V) on the C-terminus of all four
GluN2 paralogs (GluN2A-D). This promiscuous in vitro
interaction between paralogs in two gene families gen-
erates combinatorial complexity and predicts that in vivo
there are potentially sixteen pair-wise interactions that
would generate at least as many different supercom-
plexes. However, rather than the predicted promiscuity
found in vitro, in vivo genetics and biochemistry showed
with exquisite selectivity that knockout of either PSD95
or PSD93, blocks the assembly of almost all 1.5 MDa
NMDAR-MAGUK supercomplexes [5]. Therefore, aCurrent Opinion in Neurobiology 2017, 45:139–147 single MAGUK protein alone is not sufficient for super-
complex formation; instead both PSD95 and PSD93 are
required. Even more striking was the discovery using
triple knockin mouse mutations that the canonical PDZ
ligand is entirely dispensable for assembling NMDAR-
MAGUK supercomplexes. Thus, the binary interactions
identified in vitro [31,32] have no bearing on specifying
the assembly of these proteins at the synapse in vivo.
To understand how these two MAGUK proteins inter-
acted with the NMDAR, mice carrying targeted genetic
modifications of the cytoplasmic domains of GluN2A and
GluN2B were used to identify that the 600 residue
CTD of GluN2B domain was essential, whereas the same
domain of GluN2A was not sufficient to mediate super-
complex assembly. Together these findings led to the
discovery of the ‘tripartite rule’—PSD95, PSD93 and the
GluN2B subunit specify the assembly of NMDAR-
MAGUK supercomplexes (Figure 3). In contrast to the
earlier models that relied on redundant binary interac-
tions, the tripartite genetic rule provides an example of
molecular diversity involving two paralog gene families
(Glun2 and Dlg) acting as a molecular gatekeeper to limit
the inherent combinatorial diversity of higher-order
assembly in the synapse. Similar molecular interdepen-
dencies have been found outside of the synapse in
unrelated molecular machines composed of multiple
paralogous subunits [33]. Thus, the evolution of complex
proteomes following two ancestral genome duplications
appears to have adopted common mechanisms for speci-
fying self-assembly [34].
Taxonomy of NMDAR and PSD95
supercomplexes
These genetic studies of the NMDAR family not only
reveal that there are two major subfamilies, but it is also
apparent that each of these subfamilies can be further
divided into many additional members. For example, in
the case of the 0.8 MDa NMDAR complexes, which
comprise receptor tetramers, it is a family with three
members: di-heterotramers containing GluN2A-GluN1
or GluN2B-GluN1, and GluN2A-GluN2B-GluN1 tri-
heterotetramers (Figure 3b). Although there are only
GluN2B-containing di-hetetramers and tri-heterotetra-
mers in 1.5 MDa supercomplexes, this family is poten-
tially much larger because NMDAR supercomplexes
form a population containing various combinations of
50 different proteins.
To begin dissecting synaptic supercomplex subfamilies a
recent report extended the integrated gene-tagging and
biochemical approach to show that in mouse forebrain
almost all PSD95 was assembled into 1.5 MDa super-
complexes, but that only 3% of these contained
NMDARs. Thus, NMDAR supercomplexes represent
a subset of a much larger family of PSD95 supercom-
plexes that do not contain NMDARs (Figure 4).www.sciencedirect.com
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The tripartite rule governs NMDAR-MAGUK supercomplex assembly.
(a) The tripartite rule describes the genetic requirement of three proteins that are essential for the assembly of NMDA-MAGUK synaptic
supercomplexes in vivo. Schematic of NMDA receptor subunits (GluN1, GluN2, GluN3) in membrane showing the cytoplasmic tail of GluN2B
interacts with PSD95 and PSD93. The assembly of NMDAR-MAGUK supercomplexes does not depend on the ESDV C-terminal PDZ binding site.
(b) Schematic showing how subunits of NMDA receptors assemble into three receptor complex subtypes and that only those that contain GluN2B
can assemble into supercomplexes because of the tripartite rule.Examining four representative constituents of NMDAR
and PSD95 supercomplexes including two membrane-
spanning proteins (potassium channel Kir2.3 and adhe-
sion protein Adam22) and two intracellular proteins (a
signalling enzyme, IQsec2; immediate-early gene Arc/
Arg3.1) showed that these four proteins were in both
NMDAR-containing and -lacking supercomplexes. Thus,
there are at least eight subfamilies of 1.5 MDa super-
complexes (Figure 4).
The question then becomes: Are there genetic rules that
act as gatekeepers for the assembly of some of these
additional proteins? Evidence for some of thesewww.sciencedirect.com supercomplex subtypes has been garnered using mutant
mice. For example, Arc and Kir2.3 assembly into 
1.5 MDa supercomplexes required PSD95 but not
PSD93 [35]. Thus, combinations of genetic require-
ments are likely to represent a general mechanism for
specifying the type and composition of synaptic
supercomplexes.
Although it will be challenging to test mechanisms of
assembly of all synaptic proteins in vivo, other evidence
suggests the interdependency of supramolecular assem-
bly conferred by genetic rules could be prevalent in
axonal complexes [36,37] and the presynaptic terminalCurrent Opinion in Neurobiology 2017, 45:139–147
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Organization of a family of 1.5 MDa synaptic supercomplexes.
PSD95-containing supercomplexes can be subdivided into a population containing NMDA receptors (NMDAR) and those lacking NMDA receptors
(Non-NMDAR). Each of these can be further subdivided into subpopulations according to their assembly with Kir2.3, IQsec2, Adam22 or Arc.[38,39]. An emergent property of combining different
genetic requirements for assembly is that greater or lesser
selectivity can be controlled by how many constituents of
a supercomplex are indispensable. In keeping with this
mechanism, multivalent, interdependent assembly has
been well characterized in other related non-neuronal
MAGUK complexes [40].
Because the essential features of these mechanisms of
assembly are that they are genetic and hierarchical, super-
complexes can be specified within a program of develop-
ment that enables the elaboration of complex synapse
proteomes tailored to specific neuronal subtypes and at
specific times. Indeed, in mice NMDARs are expressed
from neonatal ages but NMDAR supercomplexes are
only permitted to assemble after the second postnatal
week [5], consistent with the tripartite mechanism of
assembly. The quantity of NMDAR supercomplexes
plateaus by the third postnatal week, whereas the popu-
lation of PSD95 supercomplexes continues to grow into
adulthood, consistent with the genetic evidence that
supercomplex subfamilies are regulated differentially.
Additionally, several other synaptic proteins, including
mGluR1/5 and b-catenin, have been found to partition
between different supercomplexes in the first and fifth
postnatal weeks, respectively [5]. Thus, the genetic
program that determines the timing of gene expression
together with the genetic rules for supramolecular assem-
bly control the development of the synapse.
Postsynaptic nanoclusters
New insight into synaptic architecture at length scales
above supercomplexes is being revealed by super-resolu-
tion microscopy. Until recently, light microscopy using
fluorescent labels could only resolve synaptic proteins as
single point spread functions, each marking one synapse
from another. With the higher resolution attainable by
super-resolution methods, a sub-synaptic architecture ofCurrent Opinion in Neurobiology 2017, 45:139–147 proteins concentrated into nanodomains has been discov-
ered [41–43]. This approach has shown that the apparent
concentration of PSD95 varies giving rise to nanodomains
(80 nm diameter) [41,44]. We estimate this synaptic
substructure could accommodate 30–60 supercomplexes
(assuming each 1.5 MDa supercomplex has a diameter
parallel to the membrane of 100–200 A˚). In another
example of the power of tagging endogenous genes in
the mouse, PSD95 was fused with enhanced Green
Fluorescent Protein (eGFP) or the photoconvertible fluo-
rescent protein probe, mEOS2, and brain sections were
imaged using gated Stimulated Emission Depletion (g-
STED) microscopy and PhotoActivated Localisation
Microscopy (PALM), respectively [44]. The nanostruc-
ture of >100,000 synapses in the circuitry of the hippo-
campus was examined [44] and it was clear that there is
an architecture to the organisation of synapses, where
synapses in different cells and regions of the hippocam-
pus express different numbers of nanoclusters (Figure 1).
Interestingly, these knockin fluorescent tags also revealed
a peripheral substructure of less concentrated PSD95
outside of the nanocluster that was less evident using
antibodies or over-expressed tags. Another recent study
showed that pre- and post-synaptic nanodomains may be
aligned and thereby positioning the release of neurotrans-
mitter vesicles for optimal activation of postsynaptic
supercomplexes [45]. Although at present it is unclear
if genetic rules govern the nanocluster organisation of the
synapse, there is evidence that mutations in PSD95 and
PSD93 can cause reorganization of the domains within
the postsynaptic terminal at the electron microscopic
level [46] and biochemically separable compartments
[47]. Thus, some of the same genetic rules that are
gatekeepers for supercomplex assembly may also play a
role at the level of nanodomains.
Nanodomains may also be organized as liquid–liquid
phase transition of synaptic constituents. Phasewww.sciencedirect.com
Supramolecular architecture of the synapse Frank and Grant 145transitions are self-forming protein-rich ‘droplets’ that
have been reconstituted in vitro using purified, fragments
of PSD95 and SynGAP [48]. These exciting phenom-
ena raise challenging questions, most importantly, to what
extent, if at all, these liquid–liquid phase transitions arise
in vivo with the full-length proteins at physiological
concentrations and with other competing interactions that
could occlude phase separation. The key requirements
for a phase transition, at least in vitro, are open, multiva-
lent protein–protein interactions and a very high (sub-
millimolar) protein concentration [49]. Other proteins and
posttranslational modifications could either facilitate
phase transitions by raising the local concentration or
abrogate by trapping PSD95 in closed interactions.
The assembly of NMDAR-PSD95 supercomplexes is
critically dependent on multivalent interactions because
in the absence of PSD95 or PSD93, NMDAR super-
complexes fail to assemble. Thus, it will be interesting
to understand if supercomplexes compete or complement
the phase separated state and reconcile the varying nano-
domain architectures of PSD95 detected by super-reso-
lution microscopy [44].
Anatomical diversity of synapses
There are two aspects of synapse complexity. First, it is
clear that a single synapse contains possibly hundreds of
different proteins assembled within multiple molecular
machines regulating all aspects of synaptic function. The
second factor compounding this complexity is the obser-
vation that synapses across different brain regions, neu-
ronal populations, even within the same cell, are compo-
sitionally and functionally distinct. Brain region and
neuronal-subtype specific expression of synaptic proteins
highlights this diversity. The anatomically restricted
expression of receptor subunits [50], auxiliary subunits
[51] and other constituents [52] indicate synapse compo-
sition is highly diverse. A similar pattern of diversity is
emerging at the level of supercomplexes. For example, a
population of synapses with 1.5 MDa NMDAR-Kir2.3
ion channel–channel supercomplexes were found
enriched in the ventral midbrain, whereas 1.5 MDa
Kir2.3 supercomplexes that lack NMDARs were found
in the dorsal cortex [35]. It is likely many other genetic
requirements furnish other synapse types with super-
complexes. Indeed, transsynaptic supercomplexes show
a similar pattern of anatomical specialization (reviewed
elsewhere [53]). As noted above, the PSD95 nanodomain
is also anatomically specified, with the CA3 thorny excres-
cence synapses showing 3–8 nanodomains in contrast to
CA1 stratum radiatum that typically contain 1–2 [46]. The
capacity to survey large numbers of synapses with super-
resolution microscopy opens the door to large-scale brain
mapping thereby spanning the nanometre to millimetre
length scale. We speculate that the mapping of different
complexes, supercomplexes, and nanodomains across the
entire neuroanatomy of the brain may reveal spatialwww.sciencedirect.com patterning that is influenced by the genetic rules of
supramolecular assembly.
Quantifying synaptic composition
Central to understanding the supramolecular organization
of synapses is the need to quantify proteins. Quantifica-
tion of synaptic proteins is important because the relative
abundance of subunits necessary for particular molecular
machines will contribute to shaping synaptic composition.
Mass spectrometric approaches have been useful in esti-
mating the relative and absolute abundance of proteins in
the brain [54]. However, these assays usually require
upstream biochemical fractionation before quantification
and suitable peptide standards. For example, quantifying
the molar ratio of GluN2A versus GluN2B by mass
spectrometric approaches has not been possible because
of the failure GluN2B peptide to ionize [54].
Recently, knockin mouse mutations have served as novel
tools to measure the molar ratio of endogenous mouse
brain proteins by ‘epitope matching’ the genes encoding
different proteins. This approach revealed that GluN2B
is four-fold more abundant that GluN2A in the adult
forebrain [5]. This was highly surprising since it had
long been assumed that GluN2A was the most abundant
GluN2 subunit in adult. Epitope matching using gene-
tags has also been used to quantify the relative abundance
of synaptic proteins, revealing PSD95 is 17-fold more
abundant than GluN1 and that on average each super-
complex contains on average a dimer of PSD95 [35].
Epitope matching using recombinant chimeric constructs
as standards has also been successfully applied to compare
the relative abundance of native kainic acid receptor
subunits [55].
Conclusions and perspectives
Over the last twenty years it has become clear that
synapses have a remarkable molecular complexity and
it is now also evident that this complexity is highly
regulated and organized. The supramolecular hierarchy
of complexes, supercomplexes and nanodomains repre-
sent a framework around which it is possible to describe
the architecture of synapses from the atomic to micron
length scales. In addition, evidence is now emerging that
synapse diversity is the product of the differential distri-
bution of these supramolecular building blocks. It is
therefore likely that many of the molecular machines
that define each synapse, cell or brain region have yet
to be characterized. This framework is also far from
complete and one area that will be of great importance
is the determination of the substructure of synapses using
cryo-electron microscopy and other structural approaches.
In the same way that mouse genetic approaches have
revealed key principles of synapse organisation and func-
tion in vivo when combined with biochemical and light-
microscopy methods, the versatility of these mouse
genetic reagents could, in principle, be applied to studyCurrent Opinion in Neurobiology 2017, 45:139–147
146 Molecular neurosciencethe structure of the synapse by multiple imaging
modalities.
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